Moderna has grown revenue −41% a year over three years and −21% a year over five. Revenue growth, 3-year annual rate: −41% (Biotechnology median +17%). Revenue growth, 5-year rate: −21%, growth has slowed since the five-year average. Years of annual history on file: 10, FY2016 to FY2025, as filed.

MRNAModerna

Healthcare

$62.96+93% 1Y

$62.96

$22.3652 weeks$225.03

Latest close: a new 52-week highOct 9, 2026what changed →

Is it growing?

Mixed

Neither accelerating nor breaking down: operating margin widening (+168.2 points), but revenue shrinking (−28% year on year).

1 good, 1 to watch, 1 without data

Revenue trend−28% in a year

Trailing-twelve-month revenue vs a year earlier, from the company's own filings. Five-year pace: −21% a year.

Margin direction+168.2 points operating

Trailing-twelve-month operating margin, -267.7% now against -435.9% a year earlier.

All from SEC EDGAR, as of Jun 30, 2026.

Where this answer is blind. These are trailing numbers from the filings, not forecasts: an acquisition or a one-off year can flatter them, so check the quarters.

Is MRNA growing?

Moderna has grown revenue −41% a year over three years and −21% a year over five.

−41%

Revenue growth, 3-year annual rate · Biotechnology median +17% · shrinking · compounded from trailing twelve-month revenue

Revenue growth, 5-year rate: −21%
Revenue growth, 5-year rate · −41% over three · growth has slowed since the five-year average
Years of annual history on file: 10
Years of annual history on file · FY2016 to FY2025, as filed

Details›